查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447731

器官保存市場評估：按解決方案、技術、器官類型、最終用戶和地區劃分的機會和預測（2017-2031）

Organ Preservation Market Assessment, By Solution, By Technique, By Organ Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

全球器官保存市場規模將從2023年的2.8186億美元增長到2031年的4.7176億美元，在2024年至2031年的預測期內複合年增長率為6.65%。預計規模將會增長。

受全球器官移植數量增加以及延長器官保存期限和維持高器官存活率技術進步等驅動力的影響，器官保存市場預計將呈指數級增長。事實確實如此。 此外，投資者的支持和不斷增長的醫療保健支出也正在推動市場成長。 越來越多的器官衰竭導致需要器官移植的病例也進一步增加了器官保存市場的需求。 器官移植手術的增加和器官研究的迅速增加，對器官保存解決方案的需求顯著增加。 近年來，監管日益受到重視，多種相關產品的多項監管批准加強了主要參與者的市場地位。 政府對器官移植的支持和各個非營利組織的努力也進一步推動了市場需求。 另一方面，器官移植相關的高成本和併發症是市場成長的主要挑戰。 此外，捐贈的器官與正在進行的器官移植之間的差距是市場擴張的另一個障礙。

器官移植數量增加

器官移植數量的不斷增加正在推動對器官保存產品的需求。 解剖後的器官往往會很快惡化，因此器官保存液在移植前保護器官方面發揮重要作用。 器官移植增加的原因包括臨床進步、可支配收入增加以及對器官捐贈和移植的認識提高。 根據器官取得和移植網發布的數據，2023年，死亡器官捐贈者數量將達到前所未有的高位，達到16,000人，這將是連續13年創下捐贈紀錄。 此外，年內器官移植數量急劇增加，為克服器官衰竭而實施了超過 46,000 例挽救生命的手術。 其中，肝臟移植首次突破1萬例，肺臟移植首次突破3000例。 此外，腎臟和心臟移植也創下了今年的新紀錄，凸顯了器官移植的令人矚目的進展。

器官保存方法的進展

多年來，器官保存方法逐漸進步，以優化器官移植結果。 隨後的創新包括複雜的配方，例如柯林斯、歐洲柯林斯和威斯康辛大學 (UW) 的解決方案，可延長保質期並提高器官活力。 目前，進入者正專注於開發具有復興策略的產品，特別是提供模仿生理條件的動態環境的機械灌注系統。 這些系統為器官修復和長期保存提供了機會，減少了過程失敗的可能性。 離體灌注是機械灌注的延伸之一，旨在透過進一步的修復機制和重編程過程進一步增強器官恢復。

本報告調查了全球器官保存市場，提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素分析、案例研究、競爭格局、主要公司的簡介等等。

目錄

第1章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第4章全球器官保存市場展望

  • 市場規模/預測
  • 按解決方案
    • 威斯康辛大學 (UW)
    • 託管 HTK
    • Perfadex
    • 其他
  • 按技術
    • 靜態冷庫
    • 低溫機械灌注
    • 常溫機械灌注
  • 依器官類型
    • 腎臟
    • 肝臟
    • 肺
    • 心
    • 胰臟
    • 其他
  • 按最終用戶
    • 器官移植中心
    • 醫院
    • 專科診所
  • 按地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 各公司的市佔率

第5章全球器官保存市場展望：按地區

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章市場映射

  • 按解決方案
  • 按技術
  • 依器官類型
  • 按最終用戶
  • 按地區

第7章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑制生長的因素（問題/抑制因素）

第 9 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新興技術

第10章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（主要公司）

第11章價格分析

第 12 章案例研究

第13章主要公司展望

  • XVIVO Perfusion AB
  • TransMedics, Inc.
  • Preservation Solutions, Inc.
  • Paragonix Technologies, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Waters Medical Systems LLC
  • OrganOx Limited
  • st Century Medicine Inc.
  • Bridge to Life Ltd.
  • Essential Pharmaceuticals LLC

第 14 章策略建議

第15章關於我們公司/免責聲明

Product Code: MX11138

Global organ preservation market is projected to witness a CAGR of 6.65% during the forecast period 2024-2031, growing from USD 281.86 million in 2023 to USD 471.76 million in 2031. The organ preservation market is anticipated to thrive exponentially under the influence of driving forces like the growing number of organ transplants being performed worldwide, and technological advancements to enhance the preservation time and maintain the high viability of organs. Additionally, rising investors' traction and healthcare spending also catalyze the market growth. Rising cases of organ failure leading to the requisite of organ transplantation further increase the demand in the organ preservation market. The increasing number of organ transplant procedures and the surging research being performed on organs have significantly increased the demand for organ preservation solutions. Increasing regulatory emphasis and various regulatory approvals for several relevant products in recent years have strengthened the market position of key players. Government support and initiatives taken by various non-profit organizations to facilitate organ transplants further enhance the demand in the market. However, the high cost associated with organ transplants and the complications associated with it are major challenges for market growth. The lacuna between the organs donated and organ transplants performed creates another barrier to market expansion.

Increasing Number of Organ Transplants

The increasing number of organ transplants is driving the demand for organ preservation products. Organ preservation solutions play a major role in safeguarding organs before transplantation, as isolated organs tend to deteriorate quickly. The reasons for increasing organ transplants include clinical advancements, high disposable income, and widespread awareness about organ donation and transplants. As per the data published by the Organ Procurement & Transplantation Network, in 2023, the number of deceased organ donors reached an unprecedented high of 16,000, marking 13 consecutive years of record-breaking donations. Moreover, the year witnessed an impressive increase in organ transplants, with over 46,000 life-saving procedures performed to overcome organ failures. Notably, liver transplants crossed the 10,000 mark for the first time, while lung transplants exceeded 3,000. Additionally, kidney and heart transplants also set new annual records, underscoring the remarkable progress in organ transplantation. Similarly, around 1589 kidney transplants, 761 liver, and 250 heart transplants were reported with India in the deceased category throughout the year 2022.

Advancements in Organ Preservation Methods

Organ preservation methods have progressively advanced throughout history, for the sake of optimizing organ transplantation outcomes. Subsequent innovations included refined formulations like the Collins, Euro-Collins, and University of Wisconsin (UW) solutions, which extended storage durations and enhanced organ viability. Presently, market players are focusing on developing products with revitalized strategies, particularly machine perfusion systems that offer a dynamic environment mimicking physiologic conditions. These systems provide opportunities for both organ repair and prolonged storage periods, reducing the chances of process failure. Ex vivo perfusion is one such extension of machine perfusion which aims to further enhance organ recovery through additional repair mechanisms and reprogramming processes.

In August 2023, TransMedics Group, Inc. announced the acquisition of assets and intellectual property from Bridge to Life Ltd., specifically the Ex-Vivo Organ Support System (EVOSS) and the LifeCradle Heart Preservation Transport System. LifeCradle is a cold perfusion technology used in heart transplantation, whereas EVOSS is a warm perfusion method used in lung and heart transplantation. As the company concentrates on expanding its product portfolio and applications in organ transplantation, TransMedics seeks to enhance these technologies.

Dominance of Static Cold Storage Technique

Static cold storage is preferred for organ preservation because it is a simple, cost-effective, and widely adopted method. It involves flushing the procured organ with preservation solution at a very low temperature and then immersing it in the same solution at the same temperature until transplantation. This technique significantly slows down cellular metabolism and maintains organ integrity, while minimizing the need for specialized equipment and reducing costs associated with alternative methods like machine perfusion. The cost-effectiveness of the static cold storage method is the major factor strengthening the lead of this technique. The hypothermic machine perfusion system segment is anticipated to grow at a relatively faster pace with the highest CAGR as market players are constantly working on it. For instance, in May 2023, Bridge to Life, Ltd. reported meeting promising standards from an interim analysis, prompting an early enrollment conclusion for its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial (NCT05045794). This trial evaluates the clinical safety and effectiveness of the static cold storage (SCS) method, the conventional ex-vivo organ preservation technique, against a combination of SCS and hypothermic oxygenated perfusion (HOPE) using the VitaSmart Liver Machine Perfusion System. The trial is being conducted under a U.S. Food and Drug Administration (FDA)-approved investigational device exemption (IDE).

Kidney is the Most Commonly Preserved Organ

Kidneys are the most transplanted organ due to several factors. Kidney transplantation has a higher success rate, offering patients a better quality of life and increased longevity compared to remaining on dialysis. Kidney transplantation does not require removing the recipient's kidneys unless they are severely damaged or causing problems like high blood pressure or infection, making it less invasive than other types of organ transplantation. Additionally, compared to other vital organs like the heart, liver, and lungs, there are relatively more suitable kidney donors available, contributing to the frequency of kidney transplantation. Due to the high number of kidney transplants, the demand for preservation products for kidneys is anticipated to be higher. For instance, in 2023, kidney transplants in the United States reached an all-time high, with 27,329 surgeries performed as reported by the Organ Procurement and Transplantation Network (OPTN). Out of these transplantations, more than 6,900 involved living donors, with kidney transplants comprising over 90% of them. Additionally, the year saw an increase in the number of organ transplants, including kidney transplants, for Black and Hispanic individuals.

North America to be the Dominating Region

North America region is expected to dominate the market with a high-value share throughout the assessment period owing to the growing public commitment to organ donation and collaboration among donor hospitals, organ procurement organizations, and transplant hospitals, as well as advancements in organ preservation techniques and scientific breakthroughs. The United States being a medically advanced nation, has crossed the milestone of 1 million organ transplants in the year 2022. The technological advancements in the region to facilitate organ transplants have further boosted the market expansion in the region. Manufacturers also keep up their position by innovating new products.

For instance, in November 2023, Paragonix Technologies unveiled an extensive network of organ procurement, preservation, and transportation services. Seven specialized hubs have been strategically positioned across the United States to streamline coordination and support. These centers operate round the clock, featuring over 50 experienced professionals like surgeons and preservation experts, demonstrating Paragonix's commitment to revolutionizing organ transplantation.

Future Market Scenario (2024 - 2031F)

Machine perfusion is a new technique to keep organs healthy for transplantation. It works by using a special liquid that flows through the organ to keep it alive. This allows the organ to be stored for longer periods and repaired if it is damaged. Researchers are working to develop even better machine perfusion techniques and solutions to make organs even healthier before transplantation. This could lead to more successful transplants and save more lives. For instance, in March 2023, The FDA granted XT-ViVo and TimeSeal a special designation called "Breakthrough Device Designation" because they can preserve and store kidneys for up to 120 hours. These products could be used to preserve other organs and tissues. Current methods preserve organs for only 4-16 hours, leading to waste, discarding, and countless organs not being recovered. In February 2023, LivaNova PLC unveiled the Essenz Perfusion System in Europe for cardiopulmonary bypass surgical interventions. This cutting-edge device combines a sophisticated heart-lung machine with a revolutionary patient monitor, delivering real-time critical care insights during CPB procedures.

Key Players Landscape and Outlook

XVIVO Perfusion AB, TransMedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Dr. Franz Kohler Chemie GmbH, and Waters Medical Systems LLC are some of the renowned players in the organ preservation market. These companies focus on developing and supplying organ preservation solutions, such as University of Wisconsin (UW) Solution, Custodial HTK, Perfadex, and others, while employing different preservation techniques like static cold storage, hypothermic machine perfusion, and normothermic machine perfusion. Regulatory advancements and collaboration lead the way for market expansion. The market is mainly dominated by privately held companies.

In February 2024, Bridge to Life Ltd announced that it had received ISO 13485:2016 certification. This achievement highlights the company's dedication to quality and safety in its products, including Belzer UW, EasiSlush, and VitaSmart1 Machine Perfusion System (Europe). The certification is a strategic move in preparation for the launch of the VitaSmart1 Machine Perfusion System in the US, pending FDA approval. Bridge to Life consistently strives to meet and surpass industry standards.

In February 2024, Atrium Health's Transplant Division, Carolinas Medical Center, joined forces with LifeShare Carolinas and BMI OrganBank to introduce pioneering Organ Banking technology. This advanced system will expand organ preservation and reconditioning possibilities. Atrium Health is among the top five Integrated Delivery Networks in the United States.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Organ Preservation Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2.By Solution
    • 4.2.1.University of Wisconsin Solution (UW Solution)
    • 4.2.2.Custodial HTK
    • 4.2.3.Perfadex
    • 4.2.4.Other Solutions
  • 4.3.By Technique
    • 4.3.1.Static Cold Storage
    • 4.3.2.Hypothermia Machine Perfusion
    • 4.3.3.Normothermic Machine Perfusion
  • 4.4.By Organ Type
    • 4.4.1.Kidney
    • 4.4.2.Liver
    • 4.4.3.Lung
    • 4.4.4.Heart
    • 4.4.5.Pancreas
    • 4.4.6.Others
  • 4.5.By End-user
    • 4.5.1.Organ Transplant Centers
    • 4.5.2.Hospitals
    • 4.5.3.Specialty Clinics
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Organ Preservation Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Solution
      • 5.1.2.1.University of Wisconsin Solution (UW Solution)
      • 5.1.2.2.Custodial HTK
      • 5.1.2.3.Perfadex
      • 5.1.2.4.Other Solutions
    • 5.1.3.By Technique
      • 5.1.3.1.Static Cold Storage
      • 5.1.3.2.Hypothermia Machine Perfusion
      • 5.1.3.3.Normothermic Machine Perfusion
    • 5.1.4.By Organ Type
      • 5.1.4.1.Kidney
      • 5.1.4.2.Liver
      • 5.1.4.3.Lung
      • 5.1.4.4.Heart
      • 5.1.4.5.Pancreas
      • 5.1.4.6.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Organ Transplant Centers
      • 5.1.5.2.Hospitals
      • 5.1.5.3.Specialty Clinics
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Solution
      • 5.1.6.2.1.University of Wisconsin Solution (UW Solution)
      • 5.1.6.2.2.Custodial HTK
      • 5.1.6.2.3.Perfadex
      • 5.1.6.2.4.Other Solutions
      • 5.1.6.3.By Technique
      • 5.1.6.3.1.Static Cold Storage
      • 5.1.6.3.2.Hypothermia Machine Perfusion
      • 5.1.6.3.3.Normothermic Machine Perfusion
      • 5.1.6.4.By Organ Type
      • 5.1.6.4.1.Kidney
      • 5.1.6.4.2.Liver
      • 5.1.6.4.3.Lung
      • 5.1.6.4.4.Heart
      • 5.1.6.4.5.Pancreas
      • 5.1.6.4.6.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Organ Transplant Centers
      • 5.1.6.5.2.Hospitals
      • 5.1.6.5.3.Specialty Clinics
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Solution
  • 6.2.By Technique
  • 6.3.By Organ Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.XVIVO Perfusion AB
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.TransMedics, Inc.
  • 13.3.Preservation Solutions, Inc.
  • 13.4.Paragonix Technologies, Inc.
  • 13.5.Dr. Franz Kohler Chemie GmbH
  • 13.6.Waters Medical Systems LLC
  • 13.7.OrganOx Limited
  • 13.8.21st Century Medicine Inc.
  • 13.9.Bridge to Life Ltd.
  • 13.10.Essential Pharmaceuticals LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 4.Global Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 5.Global Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 6.Global Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Organ Preservation Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 11.North America Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 12.North America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 13.North America Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 18.United States Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 19.United States Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 20.United States Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 24.Canada Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 25.Canada Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 26.Canada Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 30.Mexico Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 31.Mexico Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 32.Mexico Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 36.Europe Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 37.Europe Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 38.Europe Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 43.Germany Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 44.Germany Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 45.Germany Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 49.France Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 50.France Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 51.France Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 55.Italy Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 56.Italy Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 57.Italy Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 61.United Kingdom Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 62.United Kingdom Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 63.United Kingdom Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 67.Russia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 68.Russia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 69.Russia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 73.Netherlands Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 74.Netherlands Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 75.Netherlands Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 79.Spain Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 80.Spain Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 81.Spain Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 85.Turkey Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 86.Turkey Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 87.Turkey Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 91.Poland Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 92.Poland Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 93.Poland Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 97.South America Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 98.South America Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 99.South America Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 104.Brazil Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 105.Brazil Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 106.Brazil Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 110.Argentina Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 111.Argentina Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 112.Argentina Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 116.Asia-Pacific Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 117.Asia-Pacific Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 118.Asia-Pacific Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 120.India Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 123.India Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 124.India Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 125.India Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 129.China Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 130.China Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 131.China Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 135.Japan Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 136.Japan Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 137.Japan Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 141.Australia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 142.Australia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 143.Australia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 147.Vietnam Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 148.Vietnam Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 149.Vietnam Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 153.South Korea Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 154.South Korea Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 155.South Korea Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 159.Indonesia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 160.Indonesia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 161.Indonesia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 165.Philippines Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 166.Philippines Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 167.Philippines Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 171.Middle East & Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 172.Middle East & Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 173.Middle East & Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Organ Preservation Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 178.Saudi Arabia Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 179.Saudi Arabia Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 180.Saudi Arabia Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 184.UAE Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 185.UAE Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 186.UAE Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Organ Preservation Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Organ Preservation Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Organ Preservation Market Share (%), By Solution, 2017-2031F
  • Figure 190.South Africa Organ Preservation Market Share (%), By Technique, 2017-2031F
  • Figure 191.South Africa Organ Preservation Market Share (%), By Organ Type, 2017-2031F
  • Figure 192.South Africa Organ Preservation Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Solution Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Organ Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023